Irrimax Corporation
Cathy Douglas is an experienced professional with a diverse background spanning over two decades, focusing on quality analysis, account management, document control, operations, and customer service. Currently, Cathy serves as a Quality Analyst at IrriMax Corporation, where responsibilities include analyzing and resolving quality issues while maintaining compliance with FDA and international regulations. Previous roles include Account Manager at Watts Exhibits & Events, Operations & Distribution at Medical Enterprises Distribution, and Sr. Document Control Advisor at Becton Dickinson, emphasizing expertise in document management and regulatory compliance in the medical device sector. Additionally, Cathy has significant experience in meeting planning and customer care, having held roles with Sanofi Genzyme and Cardinal Health, respectively. Cathy has also demonstrated leadership in managing membership services with the Women's Basketball Coaches Association.
Irrimax Corporation
Irrimax Corporation is focused on treating and preventing infections, reducing healthcare costs, improving patient outcomes and increasing the safety of healthcare professionals.Innovation Technologies, Inc., parent company to Irrimax Corporation, holds the rights to US and worldwide patents that provide broad protection for the use oflow-concentration CHG (1% or less) technology. The company’s flagship product, Irrisept, is jet lavage containing low concentration Chlorhexidine Gluconate (CHG) 0.05% in sterile water for irrigation.Irrimax has attracted experts in the fields of product development, clinical research, manufacturing and distribution. Their management team is committed to leading the organization according to high standards of integrity and accountability. Irrimax Corporation is focused on driving innovation and improving patient outcomes.